Results 181 to 190 of about 12,125 (226)

Treatment With Tirofiban for Acute Coronary Syndrome (ACS): A Systematic Review and Network Analysis

open access: yesCurrent Medical Research and Opinion, 2012
Objective: To assess the efficacy of tirofiban in comparison to usual care or other GPIIb/IIIa antagonists (eptifibatide and abciximab). Results were analysed by drug administration with planned percutaneous coronary intervention (PCI) or as medical ...
Marcello di Nisio   +2 more
exaly   +2 more sources

Intravenous tirofiban following endovascular therapy for patients with acute large vessel occlusion stroke

International Journal of Stroke
Background: The role of intravenous (IV) tirofiban administered following endovascular therapy (EVT) for acute ischemic stroke (AIS) due to large vessel occlusion (LVO) remains uncertain.
Li-Na Zheng   +15 more
semanticscholar   +1 more source

Tirofiban versus aspirin to prevent in-stent thrombosis after emergent carotid artery stenting in acute ischemic stroke

Journal of NeuroInterventional Surgery
Background Several antithrombotic treatments during emergent carotid artery stenting (eCAS) have been proposed, but an appropriate protocol to balance risk–benefit is not well known.
M. Medina-Rodríguez   +12 more
semanticscholar   +1 more source

Tirofiban mediates neuroprotective effects in acute ischemic stroke by reducing inflammatory response.

Neuroscience
Growing evidence suggests that neuroinflammation is a critical driver of the development, worsening, and cell death observed in acute ischemic stroke (AIS). While prior research has demonstrated that tirofiban enhances functional recovery in AIS patients
Wei Liu   +8 more
semanticscholar   +1 more source

Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials

Stroke
BACKGROUND: The present study aimed to evaluate the efficacy and safety of intravenous tirofiban versus alteplase before endovascular treatment (EVT) in acute ischemic stroke patients with intracranial large vessel occlusion. METHODS: This was a post hoc
Hong-Fei Sang   +78 more
semanticscholar   +1 more source

Advancing stroke safety and efficacy through early tirofiban administration after intravenous thrombolysis: The multicenter, randomized, placebo-controlled, double-blind ASSET IT trial protocol

International Journal of Stroke
Background: Intravenous thrombolysis (IVT) is the cornerstone treatment for the acute ischemic stroke (AIS) within 4.5 h after onset. Current guidelines recommend administering antiplatelet medications 24 h after IVT.
C. Tao   +12 more
semanticscholar   +1 more source

Efficacy and Safety of Tirofiban Before Stenting for Symptomatic Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.

Neurology
BACKGROUND AND OBJECTIVES Acute stent thrombosis (AST) is not uncommon and even catastrophic during intracranial stenting angioplasty in patients with symptomatic high-grade intracranial atherosclerotic stenosis (ICAS).
Jun Zhang   +18 more
semanticscholar   +1 more source

Clinical efficacy of tirofiban in the endovascular therapy of patients with acute ischaemic stroke due to intracranial atherosclerotic disease: A meta-analysis.

Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)
OBJECT The treatment results of combination of arterial injection of tirofiban with endovascular therapy (EVT) for acute large vessel occlusion (LVO) stroke due to intracranial atherosclerotic disease (ICAD) were inconsistent.
Kangmeng Wang   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy